Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice (Q26767011)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice	scientific article

Statements

scholarly article

0 references

2 references

17 September 2019

28 September 2020

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice (English)

0 references

transplantation

0 references

autosomal dominant polycystic kidney

5 references

22 April 2019

24 June 2019

17 September 2019

19 July 2020

28 September 2020

1 reference

17 September 2019

polycystic kidney disease

1 reference

19 July 2020

medical society

1 reference

1 reference

based on heuristic

inferred from title

1 reference

28 September 2020

3

0 references

Giovambattista Capasso

5

object named as

Giovambattista Capasso

0 references

Olivier Devuyst

7

object named as

Olivier Devuyst

0 references

6

object named as

Adrian Covic

0 references

21

object named as

Wim Van Biesen

0 references

Raymond Vanholder

18

object named as

Raymond Vanholder

0 references

object named as

Roser Torra

17

0 references

object named as

Alberto Ortiz

15

0 references

Andrzej Więcek

19

object named as

Andrzej Więcek

0 references

Kai-Uwe Eckardt

9

object named as

Kai-Uwe Eckardt

0 references

Christiane Drechsler

8

object named as

Christiane Drechsler

0 references

Ron T Gansevoort

1

object named as

Ron T Gansevoort

0 references

10

object named as

Francesco Emma

0 references

13

object named as

Ziad A Massy

0 references

author name string

Mustafa Arici

2

0 references

Henrik Birn

4

0 references

Bertrand Knebelmann

11

0 references

Yannick Le Meur

12

0 references

Albert C M Ong

14

0 references

Franz Schaefer

16

0 references

Carmine Zoccali

20

0 references

language of work or name

0 references

publication date

March 2016

0 references

1 March 2016

6 references

22 April 2019

24 June 2019

17 September 2019

29 May 2020

19 July 2020

28 September 2020

Nephrology Dialysis Transplantation

6 references

22 April 2019

24 June 2019

17 September 2019

29 May 2020

19 July 2020

28 September 2020

31

0 references

3

0 references

337-48

0 references

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

6 references

Europe PubMed Central

22 April 2019

Europe PubMed Central

24 June 2019

Europe PubMed Central

17 September 2019

Europe PubMed Central

29 May 2020

Europe PubMed Central

19 July 2020

Europe PubMed Central

28 September 2020

on focus list of Wikimedia project

0 references

A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

7 April 2017

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

7 April 2017

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

7 April 2017

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

7 April 2017

Estimation of total kidney volume in autosomal dominant polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Autosomal dominant polycystic kidney disease: the changing face of clinical management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Predictors of autosomal dominant polycystic kidney disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Rare inherited kidney diseases: challenges, opportunities, and perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Type of PKD1 mutation influences renal outcome in ADPKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Estimating glomerular filtration rate from serum creatinine and cystatin C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Renal disease progression in autosomal dominant polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Polycystic kidney disease: a 2011 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Why kidneys fail in autosomal dominant polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Imaging for the prognosis of autosomal dominant polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Clinical practice. Autosomal dominant polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Comparison between siblings and twins supports a role for modifier genes in ADPKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Limitations of creatinine as a filtration marker in glomerulopathic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 September 2017

Stimulation by vasopressin of glycogen breakdown and gluconeogenesis in the perfused rat liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

31 May 2018

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV456

21 January 2018

Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with autosomal dominant polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV456

21 January 2018

Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV456

21 January 2018

Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV456

21 January 2018

Family history of renal disease severity predicts the mutated gene in ADPKD.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV456

21 January 2018

Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV456

21 January 2018

Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4762400

28 November 2018

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26908832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Volume progression in polycystic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26908832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chapter 10: Immunoglobulin A nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV456

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV456

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1093/NDT/GFV456

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

release_6l4ygvgv7ngt5g7sfngwih4e54

1 reference

https://api.fatcat.wiki/v0/release/6l4ygvgv7ngt5g7sfngwih4e54

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26767011&oldid=2118826585"